Venus Remedies
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Venus Remedies' outlook is shaped by stable revenue growth and consistent profit margins, reflecting management's commitment to maintaining operational efficiency amidst a competitive landscape. Recent earnings calls indicate a focus on expanding their portfolio in biosimilars and innovative therapies, which are critical for enhancing market share and long-term growth. This strategic direction aligns with Vista's forecast of stable revenue growth, as the company capitalizes on favorable industry dynamics, including improving pricing power and a robust pipeline of new products. The Indian pharmaceutical sector is experiencing expansion, supported by currency depreciation benefits and increasing export opportunities, which further bolsters Venus Remedies' revenue potential. However, the company must navigate margin pressures stemming from rising input costs, particularly in the US market. Over the next 12-24 months, key opportunities lie in leveraging their R&D capabilities to introduce higher-margin products, while watchpoints include the potential impact of fluctuating crude oil prices and competitive pressures from larger players in the market. Overall, Vista's investment outlook remains cautiously optimistic, with a target price reflecting a modest expected upside, underpinned by a stable financial structure and fair valuation
Why We Like This Stock
Things To Watch Out For
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 596 | 640 | 770 | 885 | 930 |
| Profit Before Tax (Cr.) | 44 | 60 | 134 | 191 | 191 |
| PBT Margin | 7.5% | 9.4% | 1740.3% | 21.6% | 20.5% |
| Net Profit (Cr.) | 32 | 44 | 101 | 144 | 144 |
| Earnings Per Share | 24.2 | 33.2 | 75.4 | 107.6 | 107.6 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.